United Laboratories International Holdings (STU:UNJ) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:UNJ United Laboratories International Holdings Ltd STU:UNJ
65 GF Score
Price €1.00
GF Value €0.93
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


United Laboratories International Holdings Valuation Rank Related Terms

STU:UNJ
65GF Score
United Laboratories International Holdings Ltd STU:UNJ
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is United Laboratories International Holdings (STU:UNJ) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued. The current stock price of €1.00 is trading 7% above its estimated GF Value™ of €0.93. GuruFocus considers United Laboratories International Holdings to be Fairly Valued.

Key valuation signals for STU:UNJ:

  • Valuation Rank:
  • GF Value™: €0.93 vs. price of €1.00 (7% above fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the STU:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


United Laboratories International Holdings Business Description

Other Exchanges ULIHF:USA03933:Hong Kong
Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
65GF Score

Get the complete analysis for STU:UNJ

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€0.93
GF Value